{"protocolSection":{"identificationModule":{"nctId":"NCT03814382","orgStudyIdInfo":{"id":"2018P002480"},"organization":{"fullName":"Massachusetts General Hospital","class":"OTHER"},"briefTitle":"Acupuncture to Reduce Anxiety in Alzheimer's Disease (AD) and AD Related Dementias","officialTitle":"Exploring the Use of Acupuncture to Reduce Agitation, Irritability and Anxiety in Alzheimer's Disease and Alzheimer's Disease Related Dementias Utilizing Noninvasive Measures of Autonomic Nervous System Physiology and Actigraphy Biomarkers"},"statusModule":{"statusVerifiedDate":"2022-01","overallStatus":"TERMINATED","whyStopped":"Termination of study funding","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2019-03-11","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2020-01-17","type":"ACTUAL"},"completionDateStruct":{"date":"2020-02-01","type":"ACTUAL"},"studyFirstSubmitDate":"2018-12-19","studyFirstSubmitQcDate":"2019-01-18","studyFirstPostDateStruct":{"date":"2019-01-24","type":"ACTUAL"},"resultsFirstSubmitDate":"2021-05-26","resultsFirstSubmitQcDate":"2022-01-06","resultsFirstPostDateStruct":{"date":"2022-02-03","type":"ACTUAL"},"lastUpdateSubmitDate":"2022-01-06","lastUpdatePostDateStruct":{"date":"2022-02-03","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Steven E Arnold","investigatorTitle":"Managing Director Physician","investigatorAffiliation":"Massachusetts General Hospital"},"leadSponsor":{"name":"Massachusetts General Hospital","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":true,"isUsExport":false},"descriptionModule":{"briefSummary":"The purpose of this study is to investigate the influence of acupuncture on heart rate variability, skin conductance (sweating), and rated behavioral expression of agitation, irritability, and anxiety and mood in qualifying adults with a diagnosis of cognitively unimpaired, or probable Alzheimer's Disease, Frontotemporal Dementia or Dementia with Lewy Bodies. Study subjects will all receive one real acupuncture treatment; mood scales will be assessed before and after.\n\nMassachusetts General Hospital is paying for this research to be done.","detailedDescription":"Acupuncture is a system of integrative medicine that involves pricking the skin or tissues with needles, used to alleviate pain and to treat various physical, mental, and emotional conditions. Originating in ancient China, acupuncture is now widely practiced globally."},"conditionsModule":{"conditions":["Alzheimer's Dementia With Behavioral Disturbance"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"SUPPORTIVE_CARE","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":10,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Acupuncture","type":"EXPERIMENTAL","description":"All subjects will receive up to 10 needles for 20 minutes for 1 treatment using acupuncture needles.","interventionNames":["Device: Acupuncture needle"]}],"interventions":[{"type":"DEVICE","name":"Acupuncture needle","description":"Acupuncture needle","armGroupLabels":["Acupuncture"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Heart Rate Variability as Measured by BioStamp","description":"We propose that acupuncture might acutely change Heart Rate Variability in AD/ADRD subjects with AIA. BioStamp will continuously measure participants' heart rate for 48 hours.","timeFrame":"24 hours"},{"measure":"Galvanic Skin Response","description":"We propose that acupuncture might acutely change Galvanic Skin Response in AD/ADRD subjects with AIA. Galvanic Skin Response measures sweating output in participants' fingers. The sweating response will be captured at both study visits.","timeFrame":"24 hours"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Ages 55-95 inclusive, male or female.\n* Diagnosis of CU, or probable AD, FTD or DLB as determined by established clinical criteria at screening14.\n* For the AIA symptomatic groups, a score of \\> 2 for Severity on at least 1 of the AIA-relevant items on the NPI-Q, i.e., Anxiety, Irritability/Lability, Agitation or Aggression.\n* For the CU and no neuropsychiatric symptoms group, NPI-Q score must be 0 for AIA-relevant items, i.e., Anxiety, Irritability/Lability, Agitation or Aggression.\n* No concurrent use of therapies with prohibitive effects on interpretation of HRV and SC measurements, e.g., those with major direct adrenergic or anticholinergic activities.\n* Stable doses (\\>2 weeks) of concurrent dementia or psychiatric drugs for those applicable.\n\nExclusion Criteria:\n\n* Atrial or junctional arrhythmias or other cardiac conditions, including pacemakers or other implantable devices that affect RR intervals or their measurement.\n* AIA symptoms or dementia so severe that subject cannot assent and cooperate with all study procedures or requires immediate rescue medication for behavioral control.\n* Seizure disorders or other potentially confounding medical, neurological or longstanding psychiatric illnesses.","healthyVolunteers":true,"sex":"ALL","minimumAge":"55 Years","maximumAge":"95 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Alison McManus","affiliation":"MGH","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Clinical Translational Research Unit","city":"Charlestown","state":"Massachusetts","zip":"02124","country":"United States","geoPoint":{"lat":42.37787,"lon":-71.062}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"Acupuncture","description":"All subjects will receive up to 10 needles for 20 minutes for 1 treatment using acupuncture needles.\n\nAcupuncture needle: Acupuncture needle"}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"10"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"10"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Acupuncture","description":"All subjects will receive up to 10 needles for 20 minutes for 1 treatment using acupuncture needles.\n\nAcupuncture needle: Acupuncture needle"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"10"}]}],"measures":[{"title":"Age, Categorical","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"<=18 years","measurements":[{"groupId":"BG000","value":"0"}]},{"title":"Between 18 and 65 years","measurements":[{"groupId":"BG000","value":"5"}]},{"title":">=65 years","measurements":[{"groupId":"BG000","value":"5"}]}]}]},{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"66.33","spread":"7.685"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"8"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"2"}]}]}]},{"title":"Ethnicity (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Hispanic or Latino","measurements":[{"groupId":"BG000","value":"0"}]},{"title":"Not Hispanic or Latino","measurements":[{"groupId":"BG000","value":"10"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"0"}]}]}]},{"title":"Race (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"American Indian or Alaska Native","measurements":[{"groupId":"BG000","value":"0"}]},{"title":"Asian","measurements":[{"groupId":"BG000","value":"0"}]},{"title":"Native Hawaiian or Other Pacific Islander","measurements":[{"groupId":"BG000","value":"0"}]},{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"0"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"10"}]},{"title":"More than one race","measurements":[{"groupId":"BG000","value":"0"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"0"}]}]}]},{"title":"Region of Enrollment","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"United States","categories":[{"measurements":[{"groupId":"BG000","value":"10"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Heart Rate Variability as Measured by BioStamp","description":"We propose that acupuncture might acutely change Heart Rate Variability in AD/ADRD subjects with AIA. BioStamp will continuously measure participants' heart rate for 48 hours.","populationDescription":"The data was so noisy that is was unable to be analyzed","reportingStatus":"POSTED","timeFrame":"24 hours","groups":[{"id":"OG000","title":"Acupuncture","description":"All subjects will receive up to 10 needles for 20 minutes for 1 treatment using acupuncture needles.\n\nAcupuncture needle: Acupuncture needle"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"}]}]},{"type":"PRIMARY","title":"Galvanic Skin Response","description":"We propose that acupuncture might acutely change Galvanic Skin Response in AD/ADRD subjects with AIA. Galvanic Skin Response measures sweating output in participants' fingers. The sweating response will be captured at both study visits.","populationDescription":"The data was so noisy that is was unable to be analyzed","reportingStatus":"POSTED","timeFrame":"24 hours","groups":[{"id":"OG000","title":"Acupuncture","description":"All subjects will receive up to 10 needles for 20 minutes for 1 treatment using acupuncture needles.\n\nAcupuncture needle: Acupuncture needle"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"}]}]}]},"adverseEventsModule":{"frequencyThreshold":"0","timeFrame":"48 hours","description":"AE definitions do not differ from this trial.","eventGroups":[{"id":"EG000","title":"Acupuncture","description":"All subjects will receive up to 10 needles for 20 minutes for 1 treatment using acupuncture needles.\n\nAcupuncture needle: Acupuncture needle","deathsNumAffected":0,"deathsNumAtRisk":10,"seriousNumAffected":0,"seriousNumAtRisk":10,"otherNumAffected":0,"otherNumAtRisk":10}]},"moreInfoModule":{"limitationsAndCaveats":{"description":"This study Investigated a wearable technology for HRV and galvanic skin response as an indicator of autonomic function for use in tracking people over time in clinical trials. We observed high day to day variability in measures that led us to conclude that this technology is not useful for our clinical trials in its current state."},"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"pointOfContact":{"title":"Jessica Gerber, DAc.","organization":"Massachusetts General Hospital","email":"jgerber2@mgh.harvard.edu","phone":"617-724-1992"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot_SAP","hasProtocol":true,"hasSap":true,"hasIcf":false,"label":"Study Protocol and Statistical Analysis Plan","date":"2018-12-07","uploadDate":"2021-05-05T14:47","filename":"Prot_SAP_000.pdf","size":316865}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2025-07-25","submissionTracking":{"firstMcpInfo":{"postDateStruct":{"date":"2021-06-18","type":"ACTUAL"}}}},"conditionBrowseModule":{"meshes":[{"id":"D000544","term":"Alzheimer Disease"},{"id":"D003704","term":"Dementia"},{"id":"D000066553","term":"Problem Behavior"}],"ancestors":[{"id":"D001927","term":"Brain Diseases"},{"id":"D002493","term":"Central Nervous System Diseases"},{"id":"D009422","term":"Nervous System Diseases"},{"id":"D024801","term":"Tauopathies"},{"id":"D019636","term":"Neurodegenerative Diseases"},{"id":"D019965","term":"Neurocognitive Disorders"},{"id":"D001523","term":"Mental Disorders"},{"id":"D001526","term":"Behavioral Symptoms"}],"browseLeaves":[{"id":"M4324","name":"Anxiety Disorders","relevance":"LOW"},{"id":"M6904","name":"Dementia","asFound":"Dementia","relevance":"HIGH"},{"id":"M85","name":"Problem Behavior","asFound":"Behavioral Disturbances","relevance":"HIGH"},{"id":"M14452","name":"Psychomotor Agitation","relevance":"LOW"},{"id":"M3885","name":"Alzheimer Disease","asFound":"Alzheimer's Disease","relevance":"HIGH"},{"id":"M5204","name":"Brain Diseases","relevance":"LOW"},{"id":"M5742","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M23002","name":"Tauopathies","relevance":"LOW"},{"id":"M21558","name":"Neurodegenerative Diseases","relevance":"LOW"},{"id":"M21836","name":"Neurocognitive Disorders","relevance":"LOW"},{"id":"M14473","name":"Psychotic Disorders","relevance":"LOW"},{"id":"M4815","name":"Mental Disorders","relevance":"LOW"},{"id":"M4818","name":"Behavioral Symptoms","relevance":"LOW"},{"id":"T2192","name":"Familial Alzheimer Disease","asFound":"Alzheimer's Dementia","relevance":"HIGH"}],"browseBranches":[{"abbrev":"BXM","name":"Behaviors and Mental Disorders"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":true}